BIOREM Reports Second Quarter Financial Results & Record Order Backlog
BIOREM Reports Second Quarter Financial Results & Record Order Backlog BIOREM today announced its results for the three and six-month periods ended […]
BIOREM Reports Second Quarter Financial Results & Record Order Backlog BIOREM today announced its results for the three and six-month periods ended […]
BIOREM order backlog grows to $40 million on strength of $11 million in new orders North American sales a “vote of confidence” […]
Biorem Reports First Quarter Financial Results GUELPH, ON, May 20, 2022 – BIOREM Inc. today announced results for the three month period […]
BIOREM Announces Stock Option Grant BIOREM announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to […]
BIOREM Reports 2021 Financial Results BIOREM today announced its results for the three and twelve-month periods ended December 31, 2021. BIOREM’s complete […]
BIOREM Announces Several Orders Totalling $9.2 Million and Order Backlog of $34.6 Million GUELPH, ON, February 2nd, 2022 /CNW/ – BIOREM Inc. […]
BIOREM today announced that at the special meeting of shareholders held on September 16, 2021 the shareholders approved the purchase for cancellation […]
GUELPH, ON, Aug. 5, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced that its independent directors have approved, subject to […]
GUELPH, ON, July 28, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three […]
GUELPH, ON, May 19, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced results for the three month period ended March 31, 2021. […]